Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Final Astroworld suit settled
At least 100 killed in landslide
'This means war'
Acapulco arm attack: 5 dead
'My eyeball was out'
US issues visa restrictions
'Doge' meme dog dies
Official images of B21 Raider
2022 Osprey crash lawsuit
US service members injured
Duggan can be extradited
Arrested, charged w/ fraud
Approves ETFs for Ether
Support AIDS research
Bodies of 3 hostages found
China's 2nd day of war games
Lovett joins ‘Survivor’ cast
OH gov. calls special session
ISR Rafah offensive ruling
Gets Walk of Fame star
2 shot at graduation event
To hold output policy meeting
Priest bites woman?
Daytime Emmy Awards hosts
Wins Idaho caucuses
Judge revisits immigration law
Drops ‘Dark Times' album
Ala. coal ash plan rejected
Bong's plane discovered?
AI deals with Hollywood?
First teaser revealed
CIA director to visit Europe
Planet that could support life
Pistons new president?
Lucid to cut workforce by 6%
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, Sanofi
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu shot.
Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline
Sanofi on Friday said it had reached a deal worth up to $1.2 billion to sell Novavax’s Covid shot as well as to try to combine the vaccine with its own flu shot.
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with Sanofi (SNY, FR:SAN). Novavax sha
Benefits Pro
11d
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
With flu and COVID hospital admission rates now mirroring each other,
Novavax
, which lost out in the COVID
vaccine
race ...
4d
on MSN
Shah Capital ends campaign against Novavax board after Sanofi deal
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's ...
Seeking Alpha on MSN
13d
Novavax hits 52-week high as Sanofi deal brings upgrades (update)
Novavax
(NASDAQ:NVAX) shares hit a 52-week high on Friday as the COVID-19
vaccine
maker removed its going-concern notice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback